Cargando…

Strategies to Overcome Heparins’ Low Oral Bioavailability

Even after a century, heparin is still the most effective anticoagulant available with few side effects. The poor oral absorption of heparins triggered the search for strategies to achieve oral bioavailability since this route has evident advantages over parenteral administration. Several approaches...

Descripción completa

Detalles Bibliográficos
Autores principales: Neves, Ana Rita, Correia-da-Silva, Marta, Sousa, Emília, Pinto, Madalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039490/
https://www.ncbi.nlm.nih.gov/pubmed/27367704
http://dx.doi.org/10.3390/ph9030037
_version_ 1782456066957639680
author Neves, Ana Rita
Correia-da-Silva, Marta
Sousa, Emília
Pinto, Madalena
author_facet Neves, Ana Rita
Correia-da-Silva, Marta
Sousa, Emília
Pinto, Madalena
author_sort Neves, Ana Rita
collection PubMed
description Even after a century, heparin is still the most effective anticoagulant available with few side effects. The poor oral absorption of heparins triggered the search for strategies to achieve oral bioavailability since this route has evident advantages over parenteral administration. Several approaches emerged, such as conjugation of heparins with bile acids and lipids, formulation with penetration enhancers, and encapsulation of heparins in micro and nanoparticles. Some of these strategies appear to have potential as good delivery systems to overcome heparin’s low oral bioavailability. Nevertheless, none have reached the market yet. Overall, this review aims to provide insights regarding the oral bioavailability of heparin.
format Online
Article
Text
id pubmed-5039490
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-50394902016-10-04 Strategies to Overcome Heparins’ Low Oral Bioavailability Neves, Ana Rita Correia-da-Silva, Marta Sousa, Emília Pinto, Madalena Pharmaceuticals (Basel) Review Even after a century, heparin is still the most effective anticoagulant available with few side effects. The poor oral absorption of heparins triggered the search for strategies to achieve oral bioavailability since this route has evident advantages over parenteral administration. Several approaches emerged, such as conjugation of heparins with bile acids and lipids, formulation with penetration enhancers, and encapsulation of heparins in micro and nanoparticles. Some of these strategies appear to have potential as good delivery systems to overcome heparin’s low oral bioavailability. Nevertheless, none have reached the market yet. Overall, this review aims to provide insights regarding the oral bioavailability of heparin. MDPI 2016-06-29 /pmc/articles/PMC5039490/ /pubmed/27367704 http://dx.doi.org/10.3390/ph9030037 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Neves, Ana Rita
Correia-da-Silva, Marta
Sousa, Emília
Pinto, Madalena
Strategies to Overcome Heparins’ Low Oral Bioavailability
title Strategies to Overcome Heparins’ Low Oral Bioavailability
title_full Strategies to Overcome Heparins’ Low Oral Bioavailability
title_fullStr Strategies to Overcome Heparins’ Low Oral Bioavailability
title_full_unstemmed Strategies to Overcome Heparins’ Low Oral Bioavailability
title_short Strategies to Overcome Heparins’ Low Oral Bioavailability
title_sort strategies to overcome heparins’ low oral bioavailability
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039490/
https://www.ncbi.nlm.nih.gov/pubmed/27367704
http://dx.doi.org/10.3390/ph9030037
work_keys_str_mv AT nevesanarita strategiestoovercomeheparinsloworalbioavailability
AT correiadasilvamarta strategiestoovercomeheparinsloworalbioavailability
AT sousaemilia strategiestoovercomeheparinsloworalbioavailability
AT pintomadalena strategiestoovercomeheparinsloworalbioavailability